Recent News

• 08.07.2025 - ProQR Announces Second Quarter 2025 Operating and Financial Results
• 07.28.2025 - ProQR Announces Upcoming Presentation at RNA Editing Summit
• 07.28.2025 - ProQR Announces Upcoming Presentation at RNA Editing Summit
• 07.28.2025 - ProQR Announces Upcoming Presentation at RNA Editing Summit
• 06.26.2025 - ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP
• 06.26.2025 - ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP
• 06.26.2025 - ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP
• 05.12.2025 - ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
• 05.12.2025 - ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
• 05.12.2025 - ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences

Recent Filings

• 06.26.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 06.26.2025 - EX-99.1 EX-99.1
• 06.03.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.28.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 05.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.08.2025 - EX-99.1 EX-99.1
• 05.08.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]